Over the past six months, Exponent’s shares (currently trading at $69.95) have posted a disappointing 12.5% loss, well below the S&P 500’s 13% gain. This may have investors wondering how to approach ...

William Blair analyst Andrew Nicholas upgraded Exponent (EXPO) to Outperform from Market Perform. The firm believes strength in reactive demand, ...

On November 2, Truist lowered‍ its price targ‌et for Exponent, Inc. (NASDAQ:EXPO) from $1​0‌0 to $90 while maintaining a Buy ...

Conestoga Capital Advisors, an independent investment management company based in Pennsylvania, recently disclosed a sale of roughly $24.6 million worth of Exponent stock.

Exponent is returning to a 13-week fiscal fourth quarter in 2025, which poses a headwind for comparisons since Q4 of fiscal 2024 benefited from a 14th week. For the fourth quarter of fiscal 2025 as ...

Scientific consulting firm Exponent (NASDAQ:EXPO) will be announcing earnings results this Thursday afternoon. Here’s what to ...